Skip to main content
. 2011 Apr-Jun;21(2):121–123. doi: 10.4103/0971-3026.82296

Figure 3 (A,B).

Figure 3 (A,B)

Post-RFA evaluation. CE-US (A) shows a non-enhancing nodule (arrow) in the arterial phase. Please note that the post-ablation contrast dynamics (B) of the HCC nodule shows no arterial (0.4%) enhancement